Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review

C Camarini, E de Souza Tolentino - Clinical Oral Investigations, 2022 - Springer
Objective To evaluate the effectiveness of non-surgical treatment as an alternative in the
management of central giant cell granuloma (CGCG). Material and methods A literature …

Central giant cell granuloma treated with intralesional corticosteroid injections and bisphosphonates: a long-term follow-up case study

RP de Mendonça, GP Mitre, FH Real… - Head and neck …, 2020 - Springer
Central giant cell granuloma (CGCG) is a benign intraosseous lesion of the head and neck
with potential for aggressive and locally destructive behaviour. Lesions of the maxilla tend to …

Central giant cell granuloma: off-label treatment with Denosumab in a patient with Noonan syndrome

CM Amorós, AE Bascones, RC Leone… - Journal of Stomatology …, 2024 - Elsevier
This study aims to describe the utilization of Denosumabࣨ, a human monoclonal antibody
against the RANK-L receptor, in a mandibular giant cell granuloma (GCG) with a significant …

Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws

ML Batista Severo, MLDS Lopes… - Journal of Oral …, 2018 - Wiley Online Library
Background This study analyzed the immunoexpression of calcitonin receptor (CTR) and
glucocorticoid receptor (GR) in central giant cell lesions (CGCL s) and verified potential …

Tumor-induced osteomalacia in a 3-year-old with unresectable central giant cell lesions

SS Crossen, E Zambrano, B Newman… - Journal of Pediatric …, 2017 - journals.lww.com
Tumor-induced osteomalacia (TIO) is a rare cause of hypophosphatemia involving
overproduction of fibroblast growth factor 23. TIO has been described largely in adults with …

Combination therapies for the treatment of recurrent central giant cell lesion in the maxilla: a case report

JP de Oliveira, F Olivete, ND de Oliveira… - Journal of medical case …, 2017 - Springer
Background Central giant cell lesion is a non-neoplastic proliferation, usually asymptomatic,
of unknown etiology. The purpose of this case report is to report the diagnosis and the …

8-year follow-up of central giant cell lesion mimicking apical periodontitis

AA de Carvalhosa, RMC Zandonade… - Journal of …, 2014 - Elsevier
Introduction Lesions of nonendodontic origin may mimic apical periodontitis. Central giant
cell lesions (CGCLs) are aggressive or nonaggressive benign idiopathic intraosseous …

[HTML][HTML] Intralesional corticosteroid injections as first option for management of giant cell lesion of the lower jaw in a 56-year-old patient: A case report and brief …

M Mukdad, O Barut, M Sjöström - Oral and Maxillofacial Surgery Cases, 2022 - Elsevier
Giant cell lesions of the maxillofacial region constitute a diverse group of lesions, which
frequently affect the lower jaw, and are commonly detected at younger ages, in the second …

Central giant cell granuloma of the maxilla: Long‐term follow‐up of a patient treated with an adjuvant corticosteroid

JAA de Arruda, AFL Martins, LG Abreu… - Special Care in …, 2021 - Wiley Online Library
Background Central giant cell granuloma (CGCG) is one of the most intriguing lesions of the
jaws and its nature has not yet been fully elucidated. Clinically, some CGCG behave more …

Conservative nonsurgical treatment of mandibular central giant cell granuloma in an adolescent: A case report

P Goyal, R Narula, S Bansal, S Bansal, P Garg - Pediatric Dental Journal, 2014 - Elsevier
Giant-cell reparative granuloma (GCRG) is a nonneoplastic osteolytic lesion of unknown
origin that may have an aggressive imaging appearance. Although it is a benign disease …